The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Goserelin Acetate Sustained Release Implant Market Research Report 2025
Synopsis
Goserelin acetate sustained-release implant is a polymer sustained-release implant that can gradually biodegrade in vivo. This product is a sterile, white or milky white cylindrical polymer containing goserelin acetate, placed in a syringe with a protective sleeve, and administered as a single dose. Indications for prostate cancer: This product is suitable for prostate cancer that can be treated with hormones. Breast cancer: For breast cancer in premenopausal and perimenopausal women who are eligible for hormone therapy. Endometriosis: Symptom relief includes pain relief and reducing the size and number of endometrial lesions.
Global Goserelin Acetate Sustained Release Implant market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Goserelin Acetate Sustained Release Implant market research.
Key manufacturers engaged in the Goserelin Acetate Sustained Release Implant industry include AstraZeneca, Luye Pharma, Apino Pharma, Alvogen and TerSera Therapeutics, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Goserelin Acetate Sustained Release Implant were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Goserelin Acetate Sustained Release Implant market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Goserelin Acetate Sustained Release Implant market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
AstraZeneca
Luye Pharma
Apino Pharma
Alvogen
TerSera Therapeutics
Segment by Type
3.6mg
10.8mg
Others
Segment by Application
Prostate Cancer
Breast Cancer
Endometriosis
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Goserelin Acetate Sustained Release Implant report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Goserelin acetate sustained-release implant is a polymer sustained-release implant that can gradually biodegrade in vivo. This product is a sterile, white or milky white cylindrical polymer containing goserelin acetate, placed in a syringe with a protective sleeve, and administered as a single dose. Indications for prostate cancer: This product is suitable for prostate cancer that can be treated with hormones. Breast cancer: For breast cancer in premenopausal and perimenopausal women who are eligible for hormone therapy. Endometriosis: Symptom relief includes pain relief and reducing the size and number of endometrial lesions.
Global Goserelin Acetate Sustained Release Implant market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Goserelin Acetate Sustained Release Implant market research.
Key manufacturers engaged in the Goserelin Acetate Sustained Release Implant industry include AstraZeneca, Luye Pharma, Apino Pharma, Alvogen and TerSera Therapeutics, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Goserelin Acetate Sustained Release Implant were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Goserelin Acetate Sustained Release Implant market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Goserelin Acetate Sustained Release Implant market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
AstraZeneca
Luye Pharma
Apino Pharma
Alvogen
TerSera Therapeutics
Segment by Type
3.6mg
10.8mg
Others
Segment by Application
Prostate Cancer
Breast Cancer
Endometriosis
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Goserelin Acetate Sustained Release Implant report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Goserelin Acetate Sustained Release Implant Market Overview
1.1 Product Overview and Scope of Goserelin Acetate Sustained Release Implant
1.2 Goserelin Acetate Sustained Release Implant Segment by Type
1.2.1 Global Goserelin Acetate Sustained Release Implant Market Value Comparison by Type (2023-2029)
1.2.2 3.6mg
1.2.3 10.8mg
1.2.4 Others
1.3 Goserelin Acetate Sustained Release Implant Segment by Application
1.3.1 Global Goserelin Acetate Sustained Release Implant Market Value by Application: (2023-2029)
1.3.2 Prostate Cancer
1.3.3 Breast Cancer
1.3.4 Endometriosis
1.3.5 Others
1.4 Global Goserelin Acetate Sustained Release Implant Market Size Estimates and Forecasts
1.4.1 Global Goserelin Acetate Sustained Release Implant Revenue 2018-2029
1.4.2 Global Goserelin Acetate Sustained Release Implant Sales 2018-2029
1.4.3 Global Goserelin Acetate Sustained Release Implant Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Goserelin Acetate Sustained Release Implant Market Competition by Manufacturers
2.1 Global Goserelin Acetate Sustained Release Implant Sales Market Share by Manufacturers (2018-2023)
2.2 Global Goserelin Acetate Sustained Release Implant Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Goserelin Acetate Sustained Release Implant Average Price by Manufacturers (2018-2023)
2.4 Global Goserelin Acetate Sustained Release Implant Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Goserelin Acetate Sustained Release Implant, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Goserelin Acetate Sustained Release Implant, Product Type & Application
2.7 Goserelin Acetate Sustained Release Implant Market Competitive Situation and Trends
2.7.1 Goserelin Acetate Sustained Release Implant Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Goserelin Acetate Sustained Release Implant Players Market Share by Revenue
2.7.3 Global Goserelin Acetate Sustained Release Implant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Goserelin Acetate Sustained Release Implant Retrospective Market Scenario by Region
3.1 Global Goserelin Acetate Sustained Release Implant Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Goserelin Acetate Sustained Release Implant Global Goserelin Acetate Sustained Release Implant Sales by Region: 2018-2029
3.2.1 Global Goserelin Acetate Sustained Release Implant Sales by Region: 2018-2023
3.2.2 Global Goserelin Acetate Sustained Release Implant Sales by Region: 2024-2029
3.3 Global Goserelin Acetate Sustained Release Implant Global Goserelin Acetate Sustained Release Implant Revenue by Region: 2018-2029
3.3.1 Global Goserelin Acetate Sustained Release Implant Revenue by Region: 2018-2023
3.3.2 Global Goserelin Acetate Sustained Release Implant Revenue by Region: 2024-2029
3.4 North America Goserelin Acetate Sustained Release Implant Market Facts & Figures by Country
3.4.1 North America Goserelin Acetate Sustained Release Implant Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Goserelin Acetate Sustained Release Implant Sales by Country (2018-2029)
3.4.3 North America Goserelin Acetate Sustained Release Implant Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Goserelin Acetate Sustained Release Implant Market Facts & Figures by Country
3.5.1 Europe Goserelin Acetate Sustained Release Implant Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Goserelin Acetate Sustained Release Implant Sales by Country (2018-2029)
3.5.3 Europe Goserelin Acetate Sustained Release Implant Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Goserelin Acetate Sustained Release Implant Market Facts & Figures by Country
3.6.1 Asia Pacific Goserelin Acetate Sustained Release Implant Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Goserelin Acetate Sustained Release Implant Sales by Country (2018-2029)
3.6.3 Asia Pacific Goserelin Acetate Sustained Release Implant Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Goserelin Acetate Sustained Release Implant Market Facts & Figures by Country
3.7.1 Latin America Goserelin Acetate Sustained Release Implant Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Goserelin Acetate Sustained Release Implant Sales by Country (2018-2029)
3.7.3 Latin America Goserelin Acetate Sustained Release Implant Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Goserelin Acetate Sustained Release Implant Market Facts & Figures by Country
3.8.1 Middle East and Africa Goserelin Acetate Sustained Release Implant Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Goserelin Acetate Sustained Release Implant Sales by Country (2018-2029)
3.8.3 Middle East and Africa Goserelin Acetate Sustained Release Implant Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Goserelin Acetate Sustained Release Implant Sales by Type (2018-2029)
4.1.1 Global Goserelin Acetate Sustained Release Implant Sales by Type (2018-2023)
4.1.2 Global Goserelin Acetate Sustained Release Implant Sales by Type (2024-2029)
4.1.3 Global Goserelin Acetate Sustained Release Implant Sales Market Share by Type (2018-2029)
4.2 Global Goserelin Acetate Sustained Release Implant Revenue by Type (2018-2029)
4.2.1 Global Goserelin Acetate Sustained Release Implant Revenue by Type (2018-2023)
4.2.2 Global Goserelin Acetate Sustained Release Implant Revenue by Type (2024-2029)
4.2.3 Global Goserelin Acetate Sustained Release Implant Revenue Market Share by Type (2018-2029)
4.3 Global Goserelin Acetate Sustained Release Implant Price by Type (2018-2029)
5 Segment by Application
5.1 Global Goserelin Acetate Sustained Release Implant Sales by Application (2018-2029)
5.1.1 Global Goserelin Acetate Sustained Release Implant Sales by Application (2018-2023)
5.1.2 Global Goserelin Acetate Sustained Release Implant Sales by Application (2024-2029)
5.1.3 Global Goserelin Acetate Sustained Release Implant Sales Market Share by Application (2018-2029)
5.2 Global Goserelin Acetate Sustained Release Implant Revenue by Application (2018-2029)
5.2.1 Global Goserelin Acetate Sustained Release Implant Revenue by Application (2018-2023)
5.2.2 Global Goserelin Acetate Sustained Release Implant Revenue by Application (2024-2029)
5.2.3 Global Goserelin Acetate Sustained Release Implant Revenue Market Share by Application (2018-2029)
5.3 Global Goserelin Acetate Sustained Release Implant Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Goserelin Acetate Sustained Release Implant Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AstraZeneca Goserelin Acetate Sustained Release Implant Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Luye Pharma
6.2.1 Luye Pharma Corporation Information
6.2.2 Luye Pharma Description and Business Overview
6.2.3 Luye Pharma Goserelin Acetate Sustained Release Implant Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Luye Pharma Goserelin Acetate Sustained Release Implant Product Portfolio
6.2.5 Luye Pharma Recent Developments/Updates
6.3 Apino Pharma
6.3.1 Apino Pharma Corporation Information
6.3.2 Apino Pharma Description and Business Overview
6.3.3 Apino Pharma Goserelin Acetate Sustained Release Implant Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Apino Pharma Goserelin Acetate Sustained Release Implant Product Portfolio
6.3.5 Apino Pharma Recent Developments/Updates
6.4 Alvogen
6.4.1 Alvogen Corporation Information
6.4.2 Alvogen Description and Business Overview
6.4.3 Alvogen Goserelin Acetate Sustained Release Implant Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Alvogen Goserelin Acetate Sustained Release Implant Product Portfolio
6.4.5 Alvogen Recent Developments/Updates
6.5 TerSera Therapeutics
6.5.1 TerSera Therapeutics Corporation Information
6.5.2 TerSera Therapeutics Description and Business Overview
6.5.3 TerSera Therapeutics Goserelin Acetate Sustained Release Implant Sales, Revenue and Gross Margin (2018-2023)
6.5.4 TerSera Therapeutics Goserelin Acetate Sustained Release Implant Product Portfolio
6.5.5 TerSera Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Goserelin Acetate Sustained Release Implant Industry Chain Analysis
7.2 Goserelin Acetate Sustained Release Implant Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Goserelin Acetate Sustained Release Implant Production Mode & Process
7.4 Goserelin Acetate Sustained Release Implant Sales and Marketing
7.4.1 Goserelin Acetate Sustained Release Implant Sales Channels
7.4.2 Goserelin Acetate Sustained Release Implant Distributors
7.5 Goserelin Acetate Sustained Release Implant Customers
8 Goserelin Acetate Sustained Release Implant Market Dynamics
8.1 Goserelin Acetate Sustained Release Implant Industry Trends
8.2 Goserelin Acetate Sustained Release Implant Market Drivers
8.3 Goserelin Acetate Sustained Release Implant Market Challenges
8.4 Goserelin Acetate Sustained Release Implant Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
